Journal Article DKFZ-2017-03531

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
A Functional Role for VEGFR1 Expressed in Peripheral Sensory Neurons in Cancer Pain.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2015
Cell Press Cambridge, Mass.

Cancer cell 27(6), 780 - 796 () [10.1016/j.ccell.2015.04.017]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Cancer pain is a debilitating disorder and a primary determinant of the poor quality of life. Here, we report a non-vascular role for ligands of the Vascular Endothelial Growth Factor (VEGF) family in cancer pain. Tumor-derived VEGF-A, PLGF-2, and VEGF-B augment pain sensitivity through selective activation of VEGF receptor 1 (VEGFR1) expressed in sensory neurons in human cancer and mouse models. Sensory-neuron-specific genetic deletion/silencing or local or systemic blockade of VEGFR1 prevented tumor-induced nerve remodeling and attenuated cancer pain in diverse mouse models in vivo. These findings identify a therapeutic potential for VEGFR1-modifying drugs in cancer pain and suggest a palliative effect for VEGF/VEGFR1-targeting anti-angiogenic tumor therapies.

Keyword(s): Angiogenesis Inhibitors ; Vascular Endothelial Growth Factor Receptor-1

Classification:

Contributing Institute(s):
  1. Vaskuläre Onkologie und Metastasierung (A190)
Research Program(s):
  1. 311 - Signalling pathways, cell and tumor biology (POF3-311) (POF3-311)

Appears in the scientific report 2015
Database coverage:
Medline ; BIOSIS Previews ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF >= 20 ; JCR ; NCBI Molecular Biology Database ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2017-09-27, last modified 2024-02-28


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)